Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape.
Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape.
复制标题
阿尔茨海默病的性别差异:来自多组学领域的见解。
DOI:
10.1016/j.biopsych.2021.02.968
复制
发表时间:
2022-01-01
影响因子:
10.6
通讯作者:
Cai D
中科院分区:
文献类型:
--
作者:
Guo L;Zhong MB;Zhang L;Zhang B;Cai D
Alzheimer’s disease (AD) has complex etiologies, and the impact of sex on AD varies over the course of disease development. The literature provides some evidence of sex-specific contributions to AD. However, molecular mechanisms of sex-biased differences in AD remain elusive. Multiomics data in tandem with systems biology approaches offer a new avenue to dissect sex-stratified molecular mechanisms of AD and to develop sex-specific diagnostic and therapeutic strategies for AD. Single-cell transcriptomic datasets and cell deconvolution of bulk tissue transcriptomic data provide additional insights into brain cell type–specific impact on sex-biased differences in AD. In this review, we summarize the impact of sex chromosomes and sex hormones on AD, the impact of sex-biased differences during AD development, and the interplay between sex and a major AD genetic risk factor, the APOE ε4 genotype, through the multiomics landscape. Several sex-biased molecular pathways such as neuroinflammation and bioenergetic metabolism have been identified. The importance of sex chromosome and sex hormones, as well as the associated pathways in AD pathogenesis, is further strengthened by findings from omics studies. Future research efforts should integrate the multiomics data from different brain regions and different cell types using systems biology approaches, and leverage the knowledge into a holistic examination of sex differences in AD. Advances in systems biology technologies and increasingly available large-scale multiomics datasets will facilitate future studies dissecting such complex signaling mechanisms to better understand AD pathogenesis in both sexes, with the ultimate goals of developing efficacious sex- and APOE-stratified preventive and therapeutic interventions for AD.
登录
查看更多内容
影响因子:
3.7
作者:
Boks MP;Derks EM;Weisenberger DJ;Strengman E;Janson E;Sommer IE;Kahn RS;Ophoff RA
通讯作者:
Ophoff RA
影响因子:
6.8
作者:
Bonham LW;Karch CM;Fan CC;Tan C;Geier EG;Wang Y;Wen N;Broce IJ;Li Y;Barkovich MJ;Ferrari R;Hardy J;Momeni P;Höglinger G;Müller U;Hess CP;Sugrue LP;Dillon WP;Schellenberg GD;Miller BL;Andreassen OA;Dale AM;Barkovich AJ;Yokoyama JS;Desikan RS;International FTD-Genomics Consortium (IFGC);International Parkinson’s Disease Genetics Consortium (IPDGC);International Genomics of Alzheimer’s Project (IGAP)
通讯作者:
International Genomics of Alzheimer’s Project (IGAP)
DOI:
10.1038/nri2394
发表时间:
2008-09
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Fish EN
通讯作者:
Fish EN
影响因子:
4.3
作者:
Brooks, Lavida R. K.;Mias, George, I
通讯作者:
Mias, George, I
影响因子:
9.8
作者:
Dumanski JP;Lambert JC;Rasi C;Giedraitis V;Davies H;Grenier-Boley B;Lindgren CM;Campion D;Dufouil C;European Alzheimer’s Disease Initiative Investigators;Pasquier F;Amouyel P;Lannfelt L;Ingelsson M;Kilander L;Lind L;Forsberg LA
通讯作者:
Forsberg LA